Chesapeake Energy shares skyrocketed 26.6% on Thursday, the most in two years, after board member Archie Dunham announced the purchase additional shares of the company.
According to the filing with the U.S. Securities and Exchange Commission, the Director bought 2.1 million shares of the company worth $4 million on December 21, 2018. With this purchase he nearly doubled his position in the company to more than 1% in this month.
“Since I’m in for long term, when I get the opportunity to buy when the whole market drops like it did over the last 10 days, I decided I would be foolish not to take advantage of it,” the Director said to Bloomberg in a telephonic interview.
Registering its highest gain since April 2016, the company end the day at $2.19 per share after rising nearly 27%.
Amidst a transition phase, in terms of shifting focus from gas to oil production, shares of the company tumbled by ~25% since November end after being hit by the oil rout. Consequently, cutting Chesapeake Energy’s market capitalization to just $2 billion.
CHK broke above its upper Bollinger Band on May 18, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In of the 37 cases the stock fell afterwards. This puts the odds of success at .
The 10-day RSI Indicator for CHK moved out of overbought territory on April 25, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where CHK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on May 26, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on CHK as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CHK turned negative on May 26, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CHK moved above its 50-day moving average on May 12, 2023 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHK advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 195 cases where CHK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.011) is normal, around the industry mean (5.998). P/E Ratio (1.575) is within average values for comparable stocks, (16.691). Projected Growth (PEG Ratio) (0.863) is also within normal values, averaging (55.823). Dividend Yield (0.102) settles around the average of (0.089) among similar stocks. P/S Ratio (0.853) is also within normal values, averaging (155.323).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CHK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows